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The former is the catalytic residue for phosphate transfer 1 , whereas the latter is one of the critical residues for ATP binding 2 . Mutations at the 745 position result in the loss of kinase activity 3 . The AB and BP anchors consist of residues with polar and long side chains and prefer moieties that simultaneously yield hydrogen bonds and van der Waals interactions, such as sulfuric acid and phosphoric acid derivatives (Fig. S2B in the supporting materials).
These five core anchors are conserved in protein kinases because they play important roles in the ATP binding process. Additionally, the compounds that only match the core anchors are often broad-spectrum inhibitors that affect most protein kinases. These results show that our site-moiety maps can identify the conserved interacting residues and the preferred moiety to reflect the ATP binding mechanisms and protein kinase functions.
Groups of anchor-based classification of tyrosine kinases
Several kinases are classified as Group 2 instead of Group 1, even though the residues of their CHG anchor are similar or conserved. This is because the Group 2 residue located at the 718 position on the G-loop shifts toward the C-terminal hinge region, which eliminates the CHG anchor pocket. For example, EGFR and INSR are classified into Groups 1 and 2, respectively, even though these two kinases belong to the same family and share a sequence identity of 37% ( There are two reasons for the elimination of the CH anchor in Group 3. First, some kinases (e.g., RET and EPHA7) have short side-chain residues (i.e., A/G/S/T) at positions 797 and 800 (Figs. 2C and S3C in the supporting materials); hence, these residues are unable to stabilize van der Waals interactions with compounds. Second, the side chains of the other kinases (e.g., CDK5 and STK24) at these two positions are long and pointed toward the pocket center (Fig. 2C) , eliminating this pocket. For example, residues Q85, D86, and K89 of CDK5-CMGC (corresponding to G796, C797, and D800 in EGFR-TK, respectively) have longer side-chains than EGFR-TK (Fig. S4B in the supporting materials). Of these residues, Q85 and K89 are pointed toward the pocket center, and occupy the binding pocket of the anchor. Another example is residue D109 in STK24-STE, which corresponds to residue D800
in EGFR-TK, similarly to the way in which residue K89 functions in the CDK5-CMGC kinase. Its side chain is oriented toward the pocket center, which eliminates the anchor ( Fig.   S4B in the supporting materials). These observations suggest that the side-chain orientation of the residue at the position 800 plays a key role in forming the CH anchor.
These two specific anchors in the C-terminal hinge region can be used to design type-C inhibitors for the kinases in Groups 1 and 2. The anchor residues of the CHG anchor often form van der Waals interactions with aromatic rings, heterocyclic moieties, phenols, alkenes, and enamines (Figs. S2C and S2D in the supporting materials). For example, the heterocyclic moieties can fit the CHG pocket well with an average energy of -20.3 kcal/mol statistically derived from more than 100 compounds. The major interacting moieties of the CH anchor are aromatic rings, heterocyclic moieties, enamines, and amides, which often form van der Waals or hydrogen-bonding interactions (Fig. 2B ). These moieties can form stable interactions with the anchor residues and can be used for guiding lead optimization.
Binding mode of quercetin
Quercetin showed the broadest protein kinase inhibitory activity in the kinase profiling assay because it matches three core anchors (PA, IA, and RB) without any specific anchors (Fig. 3G) . The predicted quercetin-EGFR complex indicates that the dihydroxychromone group of quercetin occupies the location occupied by the adenine of ATP. The two hydroxyl moieties of quercetin form three hydrogen bonds with the main chains of the anchor residues T790, Q791, and M793. Experimental procedure for synthesizing rosmarinic acid derivatives
RA-D1
Rosmarinic acid (0.05 g, 0.13 mmol) was dissolved in DMF (20 mL). EDCI (0.028 g, 0.18 mmol) and HOBT (0.02 g, 0.15 mmol) were added at 0°C, and the reaction mixture was stirred for 10 min. To the above reaction mixture, 2-methoxy-ethyl-amine (0.011 g, 0.15 mmol) was added, and the reaction mixture was stirred at room temperature for 16 h. After completion of the reaction, the reaction mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 x 25 mL). The combined organic layers were washed with brine (30 mL), dried over MgSO 4 and concentrated in vacuo. The crude product was dissolved in dichloromethane (15 mL) and re-precipitated through the dropwise addition of hexane (15 mL). The precipitated solid product was filtered and washed with hexane (30 mL) to afford RA-D1 (0.05 g, 86% 
RA-D2
Rosmarinic acid (0.05 g, 0.13 mmol) was dissolved in DMF (20 mL). EDCI (0.028 g, 0.18 mmol) and HOBT (0.02 g, 0.15 mmol) were added at 0°C, and the reaction mixture was stirred for 10 min. Isopropyl amine (0.009 g, 0.15 mmol) was added. The reaction mixture was stirred at room temperature until the starting materials were consumed (16 h). The reaction mixture was then diluted with water (20 mL) and extracted with ethyl acetate (3 x 25 mL). The combined organic layers were washed with brine (30 mL), dried over MgSO 4 and concentrated in vacuo. The crude product was dissolved in dichloromethane (15 mL) and re-precipitated through the dropwise addition of hexane (15 mL). The precipitated solid product was filtered and washed with hexane (30 mL) to afford RA-D2 (0.051 g, 92 % 
RA-D3
Rosmarinic acid (0.05 g, 0.13 mmol) was dissolved in DMF (20 mL) and EDCI (0.028 g, 0.18 mmol), HOBT (0.02 g, 0.15 mmol) were added at 0°C. After 10 min of stirring at 0°C, cyclopentyl amine (0.012 g, 0.15 mmol) was added, and the mixture was stirred at room temperature until the disappearance of the starting materials (16 h). The reaction mixture was then diluted with water (20 mL) and extracted with ethyl acetate (3 x 25 mL). The combined organic layers were washed with brine (30 mL), dried over MgSO 4 and concentrated in vacuo. The crude product was dissolved in dichloromethane (15 mL) and re-precipitated through the dropwise addition of hexane (15 mL). The precipitated solid product was filtered and washed with hexane (30 mL) to afford RA-D3 (0.052 g, 89% 
RA-D4
Caffeic acid (0.05 g, 0.27 mmol) was dissolved in DMF (20 mL). EDCI (0.028 g, 0.18 mmol) and HOBT (0.02 g, 0.15 mmol) were added at 0°C, and the mixture was stirred for 10 min. Dopamine hydrochloride (0.057 g, 0.30 mmol) was added to the reaction mixture. The reaction mixture was stirred at room temperature for 16 h. After the reaction was completed, the resulting mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 x 25 mL). The combined organic layers were washed with brine (30 mL), dried over MgSO 4 and concentrated in vacuo. The crude product was dissolved in dichloromethane (15 mL) and re-precipitated through the dropwise addition of hexane (15 mL). The precipitated solid product was filtered and washed with hexane (30 mL) to afford RA-D4 (0.078 g, 89% 
INSR-TK

CSNK1G1-CK1
RET In addition, the long side chain that is pointed toward the pocket center limits the formation of the binding pocket, as observed in STK24. TK  EGFR  3GT8  1  TK  ABL2  3KEX  2   TK  ERBB4  3BBT  1  TK  ERBB3  2OO8  2   TK  ERBB2  3PP0  1  TK  TEK  2PVF  2   TK  TNK2  1U54  1  TK  FGFR2  3RHX  2   TK  SYK  3EMG  1  TK  FGFR1  3A4O  2   TK  ZAP70  1U59  1  TK  LYN  1YVJ  2   TK  IGF1R  1JQH  1  TK  JAK3  1SM2  2   TK  ALK  3LCS  1  TK  ITK  3OCT  2  CK1  CSNK1G1 1IR3  2  TK  BTK  3BE2  2   TK  INSR  1MP8  2  TK  KDR  3HNG  2   TK  PTK2  3BKB  2  TK  FLT1  3LXP  2   TK  FES  1T45  2  TK  TYK2  1MQB  2   TK  KIT  1RJB  2  TK  EPHA2  3CC6  2   TK  FLT3  2I0Y  2  TK  PTK2B  2CMW  2   TK  CSF1R  2P0C  2  AGC  RPS6KA1 2IVT  3   TK  MERTK 3DKC  2  CAMK  PIM1  2QO7  3   TK  MET  3PLS  2  CMGC  CDK5  2R2P  3   TK  MST1R  1AD5  2  STE  STK24  3KUL  3   TK  HCK  1BYG  2  TK  RET  2VWU  3   TK  CSK  1QPC  2  TK  EPHA3  2REI  3   TK  LCK  2B7A  2  TK  EPHA5  3S95  3   TK  JAK2  2DQ7  2  TK  EPHA8  3A7J  3   TK  FYN  2G2I  2  TK  EPHB4  2Z7S  3   TK  ABL1  2SRC  2  TK  EPHA7  1UNL  3   TK  SRC  3EYH  2  TKL  LIMK1  1YXT  3   TK  JAK1  3GVUTable S2 . Top-ranked compounds in each group. CAMK MAPKAPK2 ≥100 ≥100 ≥100 TKL RAF1 5 ≥100 ≥100 CAMK MARK2 34 ≥100 ≥100 TKL TGFBR1 ≥100 ≥100 ≥100
Compounds
a The percentage of remaining kinase activity when the compound concentration is 10 μM. A compound with ≤50% activity has an IC50 of ≤10 μM.
